Literature DB >> 33453717

Vulnerability of subcellular structures to pathogenesis induced by rotenone in SH-SY5Y cells.

M Pokusa1, D Hajdúchová, V Menichová, A Evinová, Z Hatoková, A Kráľová-Trančíková.   

Abstract

Numerous pathological changes of subcellular structures are characteristic hallmarks of neurodegeneration. The main research has focused to mitochondria, endoplasmic reticulum, Golgi apparatus, lysosomal networks as well as microtubular system of the cell. The sequence of specific organelle damage during pathogenesis has not been answered yet. Exposition to rotenone is used for simulation of neurodegenerative changes in SH-SY5Y cells, which are widely used for in vitro modelling of Parkinson´s disease pathogenesis. Intracellular effects were investigated in time points from 0 to 24 h by confocal microscopy and biochemical analyses. Analysis of fluorescent images identified the sensitivity of organelles towards rotenone in this order: microtubular cytoskeleton, mitochondrial network, endoplasmic reticulum, Golgi apparatus and lysosomal network. All observed morphological changes of intracellular compartments were identified before alphaS protein accumulation. Therefore, their potential as an early diagnostic marker is of interest. Understanding of subcellular sensitivity in initial stages of neurodegeneration is crucial for designing new approaches and a management of neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33453717      PMCID: PMC8820512          DOI: 10.33549/physiolres.934477

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  39 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  ER stress in human hepatic cells treated with Efavirenz: mitochondria again.

Authors:  Nadezda Apostolova; Leysa J Gomez-Sucerquia; Fernando Alegre; Haryes A Funes; Victor M Victor; Maria D Barrachina; Ana Blas-Garcia; Juan V Esplugues
Journal:  J Hepatol       Date:  2013-06-17       Impact factor: 25.083

3.  Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox.

Authors:  Hui Zhou; Feng Zhang; Shih-heng Chen; Dan Zhang; Belinda Wilson; Jau-shyong Hong; Hui-Ming Gao
Journal:  Free Radic Biol Med       Date:  2011-11-03       Impact factor: 7.376

4.  Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation.

Authors:  Ji-Hee Won; Sangjun Park; Sujeong Hong; Seunghwan Son; Je-Wook Yu
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

5.  Is Parkinson's disease a lysosomal disorder?

Authors:  Andrés D Klein; Joseph R Mazzulli
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

6.  Toxin-induced and genetic animal models of Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Parkinsons Dis       Date:  2010-12-22

7.  The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson's Disease.

Authors:  Mahesh Ramalingam; Yu-Jin Huh; Yun-Il Lee
Journal:  Front Neurosci       Date:  2019-09-24       Impact factor: 4.677

Review 8.  Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease.

Authors:  Letizia Polito; Antonio Greco; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-01-31

9.  SIRT3 Protects Rotenone-induced Injury in SH-SY5Y Cells by Promoting Autophagy through the LKB1-AMPK-mTOR Pathway.

Authors:  Meng Zhang; Yong-Ning Deng; Jing-Yi Zhang; Jie Liu; Yan-Bo Li; Hua Su; Qiu-Min Qu
Journal:  Aging Dis       Date:  2018-04-01       Impact factor: 6.745

Review 10.  The Close Encounter Between Alpha-Synuclein and Mitochondria.

Authors:  Mattia Vicario; Domenico Cieri; Marisa Brini; Tito Calì
Journal:  Front Neurosci       Date:  2018-06-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.